Robinson, I.; Hochmair, M.J.; Schmidinger, M.; Absenger, G.; Pichler, M.; Nguyen, V.A.; Richtig, E.; Rainer, B.M.; Ay, L.; Jansen, C.;
et al. Assessing the Performance of a Novel Stool-Based Microbiome Test That Predicts Response to First Line Immune Checkpoint Inhibitors in Multiple Cancer Types. Cancers 2023, 15, 3268.
https://doi.org/10.3390/cancers15133268
AMA Style
Robinson I, Hochmair MJ, Schmidinger M, Absenger G, Pichler M, Nguyen VA, Richtig E, Rainer BM, Ay L, Jansen C,
et al. Assessing the Performance of a Novel Stool-Based Microbiome Test That Predicts Response to First Line Immune Checkpoint Inhibitors in Multiple Cancer Types. Cancers. 2023; 15(13):3268.
https://doi.org/10.3390/cancers15133268
Chicago/Turabian Style
Robinson, Irina, Maximilian Johannes Hochmair, Manuela Schmidinger, Gudrun Absenger, Martin Pichler, Van Anh Nguyen, Erika Richtig, Barbara Margaretha Rainer, Leyla Ay, Christian Jansen,
and et al. 2023. "Assessing the Performance of a Novel Stool-Based Microbiome Test That Predicts Response to First Line Immune Checkpoint Inhibitors in Multiple Cancer Types" Cancers 15, no. 13: 3268.
https://doi.org/10.3390/cancers15133268
APA Style
Robinson, I., Hochmair, M. J., Schmidinger, M., Absenger, G., Pichler, M., Nguyen, V. A., Richtig, E., Rainer, B. M., Ay, L., Jansen, C., PacÃfico, C., Knabl, A., Sladek, B., Gasche, N., & Valipour, A.
(2023). Assessing the Performance of a Novel Stool-Based Microbiome Test That Predicts Response to First Line Immune Checkpoint Inhibitors in Multiple Cancer Types. Cancers, 15(13), 3268.
https://doi.org/10.3390/cancers15133268
